A detailed history of Nwi Management LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Nwi Management LP holds 50,000 shares of AZN stock, worth $3.28 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$3.28 Million
Previous $3.9 Million 0.1%
% of portfolio
0.1%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $3.24 Million - $3.59 Million
-50,000 Reduced 50.0%
50,000 $3.39 Million
Q4 2022

Feb 15, 2023

SELL
$54.21 - $70.44 $10.8 Million - $14.1 Million
-200,000 Reduced 66.67%
100,000 $6.78 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $11.9 Million - $14.2 Million
200,000 Added 200.0%
300,000 $19.8 Million
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $4.85 Million - $5.8 Million
100,000 New
100,000 $5 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Nwi Management LP Portfolio

Follow Nwi Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwi Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Nwi Management LP with notifications on news.